CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure in patients with drug resistant hypertension. The Barostim neo system triggers the baroreflex, which is the body’s master blood-flow regulation system. The system is CE Marked and approved for use by hypertension patients in Europe.